Hampshire & Isle of Wight Medicines Safety Group Update
Written by ArturPysz on Friday 10th July 2026
Points relevant to Community Pharmacy from the last meeting
Points relevant to Community Pharmacy
- High-dose opioid patients
- The safety group highlighted a system wide gap in identifying and managing patients on high-dose chronic opioids.
- Community pharmacy input was specifically noted as important to support identification/management, however this activity is not currently funded.
- Steroid emergency card guidance
- A patient safety incident has prompted discussion about clearer guidance on steroid card deployment.
- Pharmacies should ensure all relevant patients are given a steroid card and advice.
- Propranolol for anxiety / overdose risk
- There is ongoing national concern around propranolol use for anxiety, especially in younger patients or those with mental health histories.
- Pharmacies: Please be aware of risk of overdose, any requests for urgent supplies, counselling, and signposting where clinically appropriate.
- Lithium monitoring and communication gaps
- A lithium toxicity case highlighted gaps in monitoring and communication between primary and secondary care.
- Pharmacies: Remain alert to lithium toxicity symptoms, renal function concerns, and escalation routes.
- Insulin safety
- Risks around withdrawing insulin from cartridges were discussed, mainly in relation to nursing practice, but the safety message is relevant across sectors.
- Pharmacies: Ensure patients are using a reusable pen and are getting a prescription item for needles with their cartridges.
- Yellow Card reporting
- The safety group discussed encouraging Yellow Card reporting, including system-related medication safety concerns.
- Pharmacies: Remember to use the Yellow Card reporting for any adverse events reported.